Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1F57

CARBOXYPEPTIDASE A COMPLEX WITH D-CYSTEINE AT 1.75 A

Summary for 1F57
Entry DOI10.2210/pdb1f57/pdb
DescriptorCARBOXYPEPTIDASE A, ZINC ION, D-CYSTEINE, ... (4 entities in total)
Functional Keywordsmetalloprotease inhibitor, hydrolase
Biological sourceBos taurus (cattle)
Cellular locationSecreted, extracellular space: P00730
Total number of polymer chains1
Total formula weight34631.99
Authors
van Aalten, D.M.,Chong, C.R.,Joshua-Tor, L. (deposition date: 2000-06-13, release date: 2000-09-06, Last modification date: 2024-11-13)
Primary citationvan Aalten, D.M.,Chong, C.R.,Joshua-Tor, L.
Crystal structure of carboxypeptidase A complexed with D-cysteine at 1.75 A - inhibitor-induced conformational changes.
Biochemistry, 39:10082-10089, 2000
Cited by
PubMed Abstract: D-Cysteine differs from the antiarthritis drug D-penicillamine by only two methyl groups on the beta-carbon yet inhibits carboxypeptidase A (CPD) by a distinct mechanism: D-cysteine binds tightly to the active site zinc, while D-penicillamine catalyzes metal removal. To investigate the structural basis for this difference, we solved the crystal structure of carboxypeptidase A complexed with D-cysteine (D-Cys) at 1.75-A resolution. D-Cys binds the active site zinc with a sulfur ligand and forms additional interactions with surrounding side chains of the enzyme. The structure explains the difference in potency between D-Cys and L-Cys and provides insight into the mechanism of D-penicillamine inhibition. D-Cys binding induces a concerted motion of the side chains around the zinc ion, similar to that found in other carboxypeptidase-inhibitor crystal structures and along a limited path. Analysis of concerted motions of CPD and CPD-inhibitor crystal structures reveals a clustering of these structures into distinct groups. Using the restricted conformational flexibility of a drug target in this type of analysis could greatly enhance efficiency in drug design.
PubMed: 10955996
DOI: 10.1021/bi000952h
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

229183

PDB entries from 2024-12-18

PDB statisticsPDBj update infoContact PDBjnumon